Tag: Jubilant Life Sciences Limited

Jubilant launches ‘JUBI-R’ (remdesivir) for COVID-19 treatment in India
COVID-19, News

Jubilant launches ‘JUBI-R’ (remdesivir) for COVID-19 treatment in India

August 4, 2020

Mysore/Mysuru: Jubilant Life Sciences Limited, an integrated global pharmaceutical and life sciences company, has announced that its subsidiary, Jubilant Generics Limited (Jubilant), has launched remdesivir for injection under the brand name ‘JUBI-R’ in the Indian market at a price of Rs. 4,700 per vial of 100 mg (lyophilized injection).  The Company will make the drug…

Jubilant Life Sciences to produce COVID-19 drug; Nanjangud plant still closed
COVID-19, News

Jubilant Life Sciences to produce COVID-19 drug; Nanjangud plant still closed

May 13, 2020

Mysore/Mysuru: Jubilant Life Sciences Limited,  an India-based Pharmaceutical and Life Sciences Company, yesterday announced that its subsidiary, Jubilant Generics Limited, has entered into a non-exclusive licensing agreement with Gilead Sciences that will grant Jubilant the right to register, manufacture and sell Gilead’s investigational drug ‘Remdesivir’, a potential therapy for COVID-19 in 127 countries including India….

ABOUT

Mysuru’s favorite and largest circulated English evening daily has kept the citizens of Mysuru informed and entertained since 1978. Over the past 41 years, Star of Mysore has been the newspaper that Mysureans reach for every evening to know about the happenings in Mysuru city. The newspaper has feature rich articles and dedicated pages targeted at readers across the demographic spectrum of Mysuru city. With a readership of over 2,50,000 Star of Mysore has been the best connection between it’s readers and their leaders; between advertisers and customers; between Mysuru and Mysureans.

CONTACT

Academy News Papers Private Limited, Publishers, Star of Mysore & Mysuru Mithra, 15-C, Industrial ‘A’ Layout, Bannimantap, Mysuru-570015. Phone no. – 0821 249 6520

To advertise on Star of Mysore, email us at

Online Edition: [email protected]
Print Editon: [email protected]
For News/Press Release: [email protected]